Complaint Counsel's Post Trial Brief - Federal Trade Commission

368. LaMont does not know of other companes that make claims that their products treat or
cure cancer. (R22 (LaMont, Dep. at 145)).
369. Until there are clincal trals, LaMont agrees that ''we don't know" whether DCO's
products would effective in battling cancer. (R22 (LaMont, Dep. at 147); LaMont, Tr.
585).
370. LaMont ''wouldn't want to have anybody say, (t)ake this, it's going to cure your colon
cancer." (R22 (LaMont, Dep. at 161)).
referrg to some doctors as Dr. Dumb-Dumb, as James
Feijo does on his radio show, is disrespectfuL. (R22 (LaMont, Dep. at 166)).
371. LaMont thinks the approach of
372. LaMont agrees that there is a danger if consumers do not continue with traditional cancer
therapy. (R22 (LaMont, Dep. at 166)).
373. LaMont personally does not th that the Feijos should be suggesting that people should
not get colonoscopies, as they suggest on their radio show. (R22 (LaMont, Dep. at 182)).
374. LaMont recognzes that there is always that danger that people wil take DCO products
and not go and see their physicians. (R22 (LaMont, Dep. at 183)).
375. LaMont has never conducted a scientific controlled study of any sort. (R22 (LaMont,
Dep. at 184); LaMont, Tr. 577).
376. LaMont does not take any DCO products. (R22 (LaMont, Dep. at 184-85)).
377. LaMont has not reviewed the medical records of anyone who has taken DCO products.
(R22 (LaMont, Dep. at 185); LaMont, Tr. 577-78).
378. LaMont has not spoken to any cancer patients who are or have been takg DCO
products. (LaMont, Tr. 583).
BioShark
James Duke. Ph.D.
379. Duke is not offerig opinions on BioShark "(b)ecause the major ingredient is an anmal,
and I don't deal in anals." (R18 (Duke, Dep. at 63)).
380. Duke was not asked to provide an opinon on BioShark. (R18 (Duke, Dep. at 64)).
381. Duke does not thi highy of
the studies that have been published on shark carilage.
(R18 (Duke, Dep. at 64); Duke, Tr. 527).
382. Duke ''was not convinced of
(R18 (Duke, Dep. at 64)).
the effcacy of shark carilage in the studies that (he) read."
33